
    
      After providing informed consent, patients will undergo screening for eligibility to
      participate in the study. Screening will start within 21 days prior to dosing.

      Subjects will have an MRI within 21 days of starting radiation. QOL and cognition measures
      will be performed within 21 days of starting radiation. Radiation will be given with
      parameters determined on an individual basis by the radiation oncologist. Bevacizumab will be
      continued at 10mg/kg IV every 2 weeks. Minocycline will be given twice a day starting at
      100mg PO bid. MRI, QOL, and cognitive tests will be obtained 1, 3 and 6 months after the end
      of radiation.
    
  